These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2570047)

  • 21. An immunohistological demonstration of c-erbB-2 oncoprotein expression in primary urothelial bladder cancer.
    Gardiner RA; Samaratunga ML; Walsh MD; Seymour GJ; Lavin MF
    Urol Res; 1992; 20(2):117-20. PubMed ID: 1348155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
    Somerville JE; Clarke LA; Biggart JD
    J Clin Pathol; 1992 Jan; 45(1):16-20. PubMed ID: 1346789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
    Lovekin C; Ellis IO; Locker A; Robertson JF; Bell J; Nicholson R; Gullick WJ; Elston CW; Blamey RW
    Br J Cancer; 1991 Mar; 63(3):439-43. PubMed ID: 1672254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast.
    Sharma BK; Ray A; Kaur S; Gupta S
    Indian J Exp Biol; 1999 Mar; 37(3):223-7. PubMed ID: 10641149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study.
    Hirashima N; Takahashi W; Yoshii S; Yamane T; Ooi A
    Mod Pathol; 2001 Jun; 14(6):556-62. PubMed ID: 11406656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer?
    Pierce LJ; Merino MJ; D'Angelo T; Barker EA; Gilbert L; Cowan KH; Steinberg SM; Glatstein E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):395-403. PubMed ID: 7903962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical localization of c-erbB-2 in human breast carcinomas.
    Gusterson BA; Gullick WJ; Venter DJ; Powles TJ; Elliott C; Ashley S; Tidy A; Harrison S
    Mol Cell Probes; 1987 Dec; 1(4):383-91. PubMed ID: 3330998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-erbB-2 expression in different histological types of invasive breast carcinoma.
    Soomro S; Shousha S; Taylor P; Shepard HM; Feldmann M
    J Clin Pathol; 1991 Mar; 44(3):211-4. PubMed ID: 1672872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.
    Tsuda H; Hirohashi S; Shimosato Y; Tanaka Y; Hirota T; Tsugane S; Shiraishi M; Toyoshima K; Yamamoto T; Terada M
    Jpn J Cancer Res; 1990 Apr; 81(4):327-32. PubMed ID: 1973161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
    Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia.
    Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM
    Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-erbB-2 amplification in breast cancer: detection in formalin-fixed, paraffin-embedded tissue by in situ hybridization.
    Smith KL; Robbins PD; Dawkins HJ; Papadimitriou JM; Redmond SL; Carrello S; Harvey JM; Sterrett GF
    Hum Pathol; 1994 Apr; 25(4):413-8. PubMed ID: 7909307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
    Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
    Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
    Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
    J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
    Selim AG; El-Ayat G; Wells CA
    Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
    Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
    J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
    Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD
    J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
    Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
    Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.